Literature DB >> 12595235

Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair.

M Mateo Paz Soldán1, Arthur E Warrington, Allan J Bieber, Bogoljub Ciric, Virginia Van Keulen, Larry R Pease, Moses Rodriguez.   

Abstract

Our laboratory has identified mouse and human monoclonal antibodies that promote myelin repair in multiple models of demyelinating disease. We have proposed that these antibodies promote remyelination by directly activating central nervous system glia. Intracellular calcium concentration was monitored using a Fura2 ratiometric assay. Repair-promoting antibodies induced distinct Ca2+ signals in both astrocytes and oligodendrocytes. Astrocyte Ca2+ signaling is mediated by a phospholipase C-dependent pathway while oligodendrocyte Ca2+ signaling is mediated via AMPA-sensitive glutamate receptors. An antibody's ability to induce Ca2+ signals is statistically correlated with promotion of myelin repair. These findings support the hypothesis that remyelination-promoting antibodies are acting directly at the surface of glial cells to induce calcium-dependent physiologic reparative function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595235     DOI: 10.1016/s1044-7431(02)00018-0

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  27 in total

1.  Multiple kinase pathways regulate voltage-dependent Ca2+ influx and migration in oligodendrocyte precursor cells.

Authors:  Pablo M Paez; Daniel J Fulton; Vilma Spreur; Vance Handley; Anthony T Campagnoni
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis.

Authors:  Anne H Cross; Gregory F Wu
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

3.  Proline substitutions and threonine pseudophosphorylation of the SH3 ligand of 18.5-kDa myelin basic protein decrease its affinity for the Fyn-SH3 domain and alter process development and protein localization in oligodendrocytes.

Authors:  Graham S T Smith; Miguel De Avila; Pablo M Paez; Vilma Spreuer; Melanie K B Wills; Nina Jones; Joan M Boggs; George Harauz
Journal:  J Neurosci Res       Date:  2011-09-01       Impact factor: 4.164

4.  Classical 18.5-and 21.5-kDa isoforms of myelin basic protein inhibit calcium influx into oligodendroglial cells, in contrast to golli isoforms.

Authors:  Graham S T Smith; Pablo M Paez; Vilma Spreuer; Celia W Campagnoni; Joan M Boggs; Anthony T Campagnoni; George Harauz
Journal:  J Neurosci Res       Date:  2011-01-13       Impact factor: 4.164

Review 5.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

6.  Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.

Authors:  Farinaz Safavi; Jason P Feliberti; Cedric S Raine; Foroozan Mokhtarian
Journal:  J Neuroimmunol       Date:  2011-05-25       Impact factor: 3.478

7.  Method of identifying natural antibodies for remyelination.

Authors:  Arthur E Warrington; Moses Rodriguez
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 8.  Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies.

Authors:  Brent R Wright; Arthur E Warrington; Dale D Edberg; Dale E Edberg; Moses Rodriguez
Journal:  Arch Neurol       Date:  2009-12

9.  E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism.

Authors:  Jennifer L Luebke-Wheeler; Geir Nedredal; Le Yee; Bruce P Amiot; Scott L Nyberg
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

10.  Regulation of store-operated and voltage-operated Ca2+ channels in the proliferation and death of oligodendrocyte precursor cells by golli proteins.

Authors:  Pablo M Paez; Daniel J Fulton; Vilma Spreuer; Vance Handley; Celia W Campagnoni; Anthony T Campagnoni
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.